Ameriprise’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$183M Buy
3,729,162
+388,651
+12% +$18.1M 0.04% 391
2025
Q4
$146M Buy
3,340,511
+340,958
+11% +$15.6M 0.03% 454
2025
Q3
$135M Buy
2,999,553
+319,298
+12% +$14M 0.03% 456
2025
Q2
$116M Buy
2,680,255
+1,216,535
+83% +$54.2M 0.03% 497
2025
Q1
$67.4M Buy
1,463,720
+680,826
+87% +$28.5M 0.02% 704
2024
Q4
$29.5M Sell
782,894
-108,886
-12% -$4.22M 0.01% 1118
2024
Q3
$36.2M Buy
891,780
+36,615
+4% +$1.38M 0.01% 1007
2024
Q2
$29.6M Buy
855,165
+89,551
+12% +$3.31M 0.01% 1045
2024
Q1
$28.8M Sell
765,614
-8,395
-1% -$300K 0.01% 1080
2023
Q4
$27.8M Sell
774,009
-32,853
-4% -$1.27M 0.01% 1080
2023
Q3
$30.5M Sell
806,862
-12,247
-1% -$499K 0.01% 983
2023
Q2
$33.4M Sell
819,109
-14,677
-2% -$607K 0.01% 955
2023
Q1
$34.9M Buy
833,786
+236,652
+40% +$9.86M 0.01% 926
2022
Q4
$25.8M Buy
597,134
+41,352
+7% +$1.63M 0.01% 1068
2022
Q3
$20.9M Sell
555,782
-400
-0.1% -$17.7K 0.01% 1155
2022
Q2
$25.1M Sell
556,182
-101,205
-15% -$4.76M 0.01% 1059
2022
Q1
$30.6M Sell
657,387
-673,558
-51% -$28.5M 0.01% 1054
2021
Q4
$52.2M Buy
1,330,945
+565,537
+74% +$21.3M 0.01% 820
2021
Q3
$26.4M Sell
765,408
-112,390
-13% -$3.84M 0.01% 1075
2021
Q2
$27.8M Sell
877,798
-2,051,476
-70% -$66M 0.01% 1121
2021
Q1
$91.4M Sell
2,929,274
-730,776
-20% -$22M 0.03% 537
2020
Q4
$110M Sell
3,660,050
-2,015,048
-36% -$59.5M 0.04% 440
2020
Q3
$148M Sell
5,675,098
-4,310,665
-43% -$114M 0.06% 316
2020
Q2
$258M Sell
9,985,763
-3,662,780
-27% -$97.2M 0.11% 198
2020
Q1
$360M Sell
13,648,543
-71,747
-0.5% -$2.26M 0.19% 119
2019
Q4
$446M Buy
13,720,290
+14,545
+0.1% +$471K 0.19% 117
2019
Q3
$472M Buy
13,705,745
+3,126,868
+30% +$105M 0.21% 98
2019
Q2
$362M Buy
10,578,877
+4,309,129
+69% +$152M 0.16% 129
2019
Q1
$224M Buy
6,269,748
+3,130,272
+100% +$107M 0.1% 215
2018
Q4
$101M Sell
3,139,476
-436,336
-12% -$14M 0.05% 367
2018
Q3
$111M Sell
3,575,812
-618,814
-15% -$19M 0.04% 422
2018
Q2
$127M Sell
4,194,626
-247,966
-6% -$7.1M 0.06% 337
2018
Q1
$124M Sell
4,442,592
-477,597
-10% -$12.9M 0.06% 326
2017
Q4
$138M Sell
4,920,189
-424,299
-8% -$12.2M 0.06% 312
2017
Q3
$144M Buy
5,344,488
+87,128
+2% +$2.33M 0.07% 291
2017
Q2
$135M Buy
5,257,360
+437,131
+9% +$11.1M 0.07% 296
2017
Q1
$124M Buy
4,820,229
+136,203
+3% +$3.47M 0.06% 304
2016
Q4
$119M Buy
4,684,026
+1,307,163
+39% +$31M 0.06% 305
2016
Q3
$80.2M Sell
3,376,863
-829,403
-20% -$20.8M 0.04% 392
2016
Q2
$109M Buy
4,206,266
+271,877
+7% +$6.73M 0.06% 284
2016
Q1
$101M Sell
3,934,389
-1,263,760
-24% -$28.3M 0.06% 302
2015
Q4
$103M Sell
5,198,149
-184,578
-3% -$3.74M 0.06% 299
2015
Q3
$114M Buy
5,382,727
+4,597,227
+585% +$103M 0.07% 266
2015
Q2
$17.6M Sell
785,500
-135,112
-15% -$3.24M 0.01% 1104
2015
Q1
$22.1M Buy
920,612
+77,867
+9% +$1.93M 0.01% 942
2014
Q4
$22.3M Buy
842,745
+237,175
+39% +$6.09M 0.01% 898
2014
Q3
$14.7M Buy
605,570
+43,266
+8% +$1.01M 0.01% 1158
2014
Q2
$14.6M Sell
562,304
-208,182
-27% -$5.31M 0.01% 1252
2014
Q1
$18.5M Sell
770,486
-149,355
-16% -$3.14M 0.01% 1053
2013
Q4
$18M Buy
919,841
+455,619
+98% +$9.17M 0.01% 1068
2013
Q3
$9.81M Sell
464,222
-9,357
-2% -$205K 0.01% 1484
2013
Q2
$10.4M Buy
+473,579
New +$11.5M 0.01% 1403

Other funds holding EXC

Ameriprise's EXC Position: Q1 2026 in Review

Ameriprise increased its Exelon (EXC) stake by 12% in Q1 2026, buying an estimated $18.1M and bringing the position to 3,729,162 shares worth $183M. The position accounts for 0.04% of the portfolio, ranked #391.

Ameriprise first reported a position in EXC in Q2 2013 and has held it in 52 quarters since. The position peaked at $472M in Q3 2019. 1,277 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

  • Ameriprise held 3,729,162 shares of Exelon worth $183M as of Q1 2026.
  • Ameriprise bought 388,651 Exelon shares in Q1 2026, an estimated $18.1M.
  • Exelon made up 0.04% of Ameriprise's portfolio in Q1 2026, its #391 holding.
  • Ameriprise first reported a position in Exelon in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's Exelon position peaked at $472M in Q3 2019.
  • 1,277 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.